Lieb, E. and Milz, S. and Vogel, T. and Hacker, M. and Dauner, M. and Schulz, Michaela B. (2004) Effects of transforming growth factor beta(1) on bonelike tissue formation in three-dimensional cell culture - I. Culture conditions and tissue formation. TISSUE ENGINEERING, 10 (9-10). pp. 1399-1413. ISSN 2152-4947,
Full text not available from this repository. (Request a copy)Abstract
Bone tissue engineering based on growing bone marrow stromal cells on poly(L-lactic-co-glycolic acid) fiber meshes suffers from limited matrix production and mineralization when the cells are cultured with the standard differentiation supplements ( dexamethasone, beta-glycerophosphate, and ascorbic acid). To overcome this problem we included transforming growth factor beta(1) (TGF-beta(1)), which is described as playing a key role in collagen type I formation, although its effect on mineralization is controversially discussed. The investigations focused on establishing culture conditions for the application of TGF-beta(1) in three-dimensional cell culture and on the effects of different doses of TGF-beta(1) (1 - 20 ng/mL) on bonelike extracellular matrix formation. Immunohistochemical staining showed that TGF-beta(1) enhanced the formation of procollagen type I, collagen type I, and collagen type V, especially under dynamic culture conditions ( orbital shaker). A long-term study confirmed positive effects on the formation of extracellular matrix, which penetrated the scaffold to a depth of 250 to 300 mum. Mineralization, qualified by scanning electron microscopy in combination with energy-dispersive X-ray analysis and evaluated by determination of the Ca2+ content per scaffold, was up to 1.7-fold increased by TGF-beta(1) compared with the control. In conclusion, the growth factor TGF-beta1 seems to be effective in improving extracellular bonelike matrix formation in vitro.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | MARROW STROMAL CELLS; HUMAN OSTEOBLASTS; DIFFERENTIATION; EXPRESSION; VITRO; PROLIFERATION; CULTIVATION; ERK; |
| Subjects: | 600 Technology > 615 Pharmacy |
| Divisions: | Chemistry and Pharmacy > Institute of Pharmacy > Pharmaceutical Technology (Prof. Göpferich) |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 30 Jun 2021 10:07 |
| Last Modified: | 30 Jun 2021 10:07 |
| URI: | https://pred.uni-regensburg.de/id/eprint/37308 |
Actions (login required)
 |
View Item |
